Hong Kong, China – January 11^th, 2016 – Impulse Dynamics NV (Impulse), the developer of the Optimizer™ IVs implantable device, is pleased to announce the official opening of its Hong Kong sales and support office. The Optimizer IVs is a minimally invasive implantable device designed to treat heart failure.  The device is based on novel Cardiac Contractility Modulation (CCM) technology, and delivers non-excitatory electric pulses to the heart muscle.

“I am proud and excited to bring Impulse Dynamics’ innovative chronic heart failure treatment CCM direct to the Hong Kong market” said Vilana Chan, Impulse’s Sales and Marketing Manager, who leads the Hong Kong office.

“Impulse continues to make good progress on all fronts. 2015 saw Impulse and CCM break into 6 new territories. Early in 2016 we are opening our first office in Asia. I personally look forward to supporting Vilana and our Hong Kong customers and patients” says Impulse CEO Simos Kedikoglou.  “CCM is a technology that meets a major clinical need to improve performance and daily life of patients with heart failure that are not adequately controlled with pharmaceutical treatment alone, and we are committed to expanding its global introduction to benefit more patients.”